Bone marrow mesenchymal stem cell-derived exosomes miR-367-3p, in Erastin-induced BV2 cells, targets the binding enhancer of zeste homolog 2 (EZH2), inhibiting its expression
When BMI and comorbidity thresholds are met for anti obesity pharmacotherapy, GLP-1 agonists are recommended as first line or preferred pharmacologic options because of superior weight loss efficacy and cardiometabolic benefit
At the biochemical level, NNMT regulates the conversion of nicotinic acid (NA) into 1-methylnicotinamide (1-MNA)
Contrave targets food cravings and the reward response (via naltrexone) while also suppressing appetite and boosting energy (via bupropion)
Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide
How it works, results timeline, and how it compares to semaglutide